Experimental design approach applied to the development of chitosan coated poly(isobutylcyanoacrylate) nanocapsules encapsulating copaiba oil

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 536, Issue , 2018, Pages 251-258

  Xavier Junior, Francisco Humberto ^a,b   Egito, Eryvaldo Sócrates Tabosa do ^a   Morais, Andreza Rochelle do Vale ^a,b   Alencar, Everton do Nascimento ^a   Maciuk, Alexandre ^c   Vauthier, Christine ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b UNIV PARIS SUD   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Chitosan; Copaiba oil; Experimental design approach; Nanocapsules; Poly(isobutylcyanoacrylate)

Indexed keywords

CHITIN; CHITOSAN; ENCAPSULATION; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; STATISTICS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANTICANCER MOLECULES; COPAIBA OIL; ENCAPSULATION EFFICIENCY; EXPERIMENTAL DESIGN APPROACHES; INTERFACIAL POLYMERIZATION; ISOBUTYLCYANOACRYLATE; POLY(ISOBUTYLCYANOACRYLATE); SYNERGISTIC EFFECT;

NANOCAPSULES;

BUCRILATE; CHITOSAN NANOPARTICLE; COPAIBA RESIN OIL; ESSENTIAL OIL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG COATING; EXPERIMENTAL DESIGN; MOLECULAR WEIGHT; NANOENCAPSULATION; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 85014629204     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2017.02.055     Document Type: Article

References (36)

1. Ponchel, G., Irache, J., Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. 34 (1998), 191–219.
2. Petit, B., Bouchemal, K., Vauthier, C., Djabourov, M., Ponchel, G., The counterbalanced effect of size and surface properties of chitosan-coated poly(isobutylcyanoacrylate) nanoparticles on mucoadhesion due to pluronic F68 addition. Pharm. Res. 29 (2012), 943–952.
3. Guterres, S.S., Alves, M.P., Pohlmann, A.R., Polymeric nanoparticles nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights 2 (2007), 147–157.
4. Pinto Reis, C., Neufeld, R.J., Ribeiro, A.J., Veiga, F., Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2 (2006), 8–21.
5. Leite, E.A., Grabe-Guimaraes, A., Guimaraes, H.N., Machado-Coelho, G.L., Barratt, G., Mosqueira, V.C., Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices. Life Sci. 80 (2007), 1327–1334.
6. Anton, N., Benoit, J.P., Saulnier, P., Design and production of nanoparticles formulated from nano-emulsion templates—a review. J. Control. Release 128 (2008), 185–199.
7. Bravo-Osuna, I., Vauthier, C., Farabollini, A., Palmieri, G.F., Ponchel, G., Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials 28 (2007), 2233–2243.
8. Bravo-Osuna, I., Vauthier, C., Chacun, H., Ponchel, G., Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles. Eur. J. Pharm. Biopharm. 69 (2008), 436–444.
9. Thanou, M., Verhoef, J.C., Junginger, H.E., Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev. 52 (2001), 117–126.
10. Chen, C.K., Wang, Q., Jones, C.H., Yu, Y., Zhang, H., Law, W.C., Lai, C.K., Zeng, Q., Prasad, P.N., Pfeifer, B.A., Cheng, C., Synthesis of pH-responsive chitosan nanocapsules for the controlled delivery of doxorubicin. Langmuir 30 (2014), 4111–4119.
11. Illum, L., Jabbal-Gill, I., Hinchcliffe, M., Fisher, A.N., Davis, S.S., Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev. 51 (2001), 81–96.
12. Bernkop-Schnurch, A., Heinrich, A., Greimel, A., Development of a novel method for the preparation of submicron particles based on thiolated chitosan. Eur. J. Pharm. Biopharm. 63 (2006), 166–172.
13. Sousa, J.P., Brancalion, A.P., Souza, A.B., Turatti, I.C., Ambrosio, S.R., Furtado, N.A., Lopes, N.P., Bastos, J.K., Validation of a gas chromatographic method to quantify sesquiterpenes in copaiba oils. J. Pharm. Biomed. Anal. 54 (2011), 653–659.
14. Alencar, E.N., Xavier-Junior, F.H., Morais, A.R.V., Dantas, T.R.F., Dantas-Santos, N., Verissimo, L.M., Rehder, V.L.G., Chaves, G.M., Oliveira, A.G., Egito, E.S.T., Chemical characterization and antimicrobial activity evaluation of natural oil nanostructured emulsions. J. Nanosci. Nanotechnol. 15 (2015), 880–888.
15. Santos, A.O., Ueda-Nakamura, T., Dias Filho, B.P., Veiga Junior, V.F., Pinto, A.C., Nakamura, C.V., Antimicrobial activity of Brazilian copaiba oils obtained from different species of the Copaifera genus. Mem. Inst. Oswaldo Cruz 103 (2008), 277–281.
16. Gomes, N.M., Rezende, C.M., Fontes, S.P., Matheus, M.E., Fernandes, P.D., Antinociceptive activity of amazonian copaiba oils. J. Ethnopharmacol. 109 (2007), 486–492.
17. Leandro, L.M., Vargas, S., Barbosa, F.P.C., Neves, J.K., Silva, J.A., Veiga-Junior, V.F., Chemistry and biological activities of terpenoids from copaiba (Copaifera spp.) oleoresins. Molecules 17 (2012), 3866–3889.
18. Aboubakar, M., Couvreur, P., Pinto-Alphandary, H., Gouritin, B., Lacour, B., Farinotti, R., Puisieux, F., Vauthier, C., Insulin-loaded nanocapsules for oral administration: in vitro and in vivo investigation. Drug Dev. Res. 49 (2000), 109–117.
19. Patel, B.K., Parikh, R.H., Aboti, P.S., Development of oral sustained release rifampicin loaded chitosan nanoparticles by design of experiment. J. Drug Deliv. 2013 (2013), 370938–370948.
20. Couvreur, P., Kante, B., Roland, M., Guiot, P., Bauduin, P., Speiser, P., Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 31 (1979), 331–332.
21. Fallouh, N.A., Roblottreupel, L., Fessi, H., Devissaguet, J.P., Puisieux, F., Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules. Int. J. Pharm. 28 (1986), 125–132.
22. Zu, Y.G., Zhao, Q., Zhao, X.H., Zu, S.C., Meng, L., Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method. Int. J. Nanomed. 6 (2011), 3429–3441.
23. Cochran, W.G., Cox, G.M., Experimental Designs. 2nd ed., 1957, Wiley, New York.
24. Montgomery, D.C., Design and Analysis of Experiments. 7th ed., 2008, Wiley, New York.
25. Liu, H.L., Lan, Y.W., Cheng, Y.C., Optimal production of sulphuric acid by Thiobacillus thiooxidans using response surface methodology. Process. Biochem. 39 (2004), 1953–1961.
26. Sen, R., Swaminathan, I., Response surface modeling and optimization to elucidate and analyze the effects of inoculum age and size on surfactin production. Biochem. Eng. J. 21 (2004), 141–148.
27. Zandanel, C., Vauthier, C., Characterization of fluorescent poly(isobutylcyanoacrylate) nanoparticles obtained by copolymerization of a fluorescent probe during Redox Radical Emulsion Polymerization (RREP). Eur. J. Pharm. Biopharm. 82 (2012), 66–75.
28. Ganachaud, F., Katz, J.L., Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulsification as an alternative to ultrasonic and high-shear devices. Chem. Phys. Chem. 6 (2005), 209–216.
29. Gallardo, M., Couarraze, G., Denizot, B., Treupel, L., Couvreur, P., Puisieux, F., Study of the mechanisms of formation of nanoparticles and nanocapsules of polyisobutyl-2-cyanoacrylate. Int. J. Pharm. 100 (1993), 55–64.
30. Desbrieres, J., Viscosity of semiflexible chitosan solutions: influence of concentration, temperature, and role of intermolecular interactions. Biomacromolecules 3 (2002), 342–349.
31. Cournarie, F., Cheron, M., Besnard, M., Vauthier, C., Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules. Eur. J. Pharm. Biopharm. 57 (2004), 171–179.
32. McCarron, P.A., Woolfson, A.D., Keating, S.M., Response surface methodology as a predictive tool for determining the effects of preparation conditions on the physicochemical properties of poly(isobutylcyanoacrylate) nanoparticles. Int. J. Pharm. 193 (1999), 37–47.
33. Ravikumara, N.R., Madhusudhan, B., Chitosan nanoparticles for tamoxifen delivery and cytotoxicity to MCF-7 and Vero cells. Pure Appl. Chem. 83 (2011), 2027–2040.
34. Yang, S.C., Ge, H.X., Hu, Y., Jiang, X.Q., Yang, C.Z., Formation of positively charged poly(butyl cyanoacrylate) nanoparticles stabilized with chitosan. Colloid. Polym. Sci. 278 (2000), 285–292.
35. Aboubakar, M., Puisieux, F., Couvreur, P., Deyme, M., Vauthier, C., Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. J. Biomed. Mater. Res. 47 (1999), 568–576.
36. Legault, J., Pichette, A., Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene, isocaryophyllene and paclitaxel. J. Pharm. Pharmacol. 59 (2007), 1643–1647.